Sales of Infection Surveillance Solutions Market to Grow at Robust CAGR 48.3% During 2025

Infection surveillance solution helps healthcare facilities in reporting patient-associated data to the state and federal authorities. Integration of infection surveillance software with already existing networks of medical facilities and hospitals is an easy process.

A recent report published by Persistence Market Research (PMR) estimates theglobalinfection surveillance solution marketto register a staggering14.04% CAGRduring the forecast- 2017 to 2025. TheUS$ 316.67 Mnmarket is likely to surpassUS$ 900 Mnin revenues by 2025-end.

Get Sample Copy of Report @https://www.persistencemarketresearch.com/samples/13543

Increased Healthcare-associated Infections to Drive the Adoption of Infection Surveillance Solution

Contamination of devices & equipment, patient clothing, and bed linens have led to various hospital-associated infections including pneumonia, urinary tract infection, and surgical site infection. To identify the possible healthcare associated infections, hospitals and healthcare professionals are being impelled to adopt infection surveillance systems.

Healthcare institutes are incorporating infection surveillance systems to seek accurate, real-time information related to medical records, surgical database, employees’ health and patient health. The aforementioned factors are driving the growth of the global infection surveillance solution market.

Governments of various economies are encouraging health communication programs within health institutes. These governments are coming up with initiatives for building a reliable data source. This further would help in exchanging information within healthcare systems.

Get To Know Methodology of Report @https://www.persistencemarketresearch.com/methodology/13543

In addition, the capacity of IT systems is witnessing a surge in performing analytic processing. These factors are expected to aid in the development of analytical and infection surveillance solutions. However, improper data management, soaring volume of data for analysis coupled with altering regulatory requirements, and rising trend of healthcare staff migration on international level are key restrains expected to inhibit the market growth over the forecast period.

Hospitals to be the Most Lucrative End User in the Market

Among end users, hospitals will be the most lucrative in the global infection surveillance solution market. Revenues amassed from hospitals would reach aroundUS$ 500 Mn by 2025-end. Clinics, the second largest end-user, are expected toexhibit 14.19% CAGR through 2025.

Although software component is projected to be most lucrative over the global infection surveillance solution market, the services component is projected to register a comparatively faster growth during the forecast period. Infection and surveillance software enables clinics and hospitals to minimize and control healthcare-associated infections in real-time.

Access Full Report @https://www.persistencemarketresearch.com/checkout/13543

North America to be Dominant in the Global Infection Surveillance Solution Market

PMR’s report projects North America to remain dominant in the market during the forecast period, followed by Europe and Asia Pacific (APAC).

The United States (U.S.) is expected to be the most lucrative country in North America infection surveillance solution market. Federal regulation in North America have driven the adoption of infection surveillance solutions by hospitals and other healthcare settings.

Europe and APAC are anticipated to exhibit 13.86% and 13.10% CAGRs respectively through 2025. Government initiatives and programs in Europe, for example- European Influenza Surveillance Scheme by European Center for Disease and Prevention Control, are fuelling the growth of the market in this region.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Molecular Diagnostics Market –

Molecular Diagnostics MarketSegmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.

Next-Generation Sequencing Market –

Next Generation Sequencing MarketSegmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.

Ophthalmology devises Market –

Ophthalmology devises MarketSegmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.

Intravenous Iron Drugs Market –

Intravenous (IV) Iron Drugs MarketSegmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., and Sanofi.

Syndromes Progressive Ataxia Weakness Disorders Market –

Treatments forSyndromes of Progressive Ataxia and Weakness Disorders MarketSegmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id-sales@persistencemarketresearch.com
Website:https://www.persistencemarketresearch.com